◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › UHS

Universal Health Services Inc (UHS) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · Health Care Facilities · DATA UPDATED 2026-07-19

Universal Health Services Inc (UHS) operates in the Health Care Facilities industry and is headquartered in King of Prussia, United States with about 101,500 employees. Its market capitalization is roughly $9 billion. In the fiscal year ended 2025-12-31, UHS reported $17.4B in revenue and $1.5B in net income.

Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities in the United States. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments.

Interactive charts & full statements → Open the UHS valuation workbench →

UHS Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Revenue$17.8B$17.4B$15.8B$14.3B$13.4B$12.6B$11.6B$11.4B$10.8B$10.4B$9.8B$9.0B$8.1B$7.3B$7.0B$7.5B$5.6B$5.2B$5.0B$4.8B$4.2B
Gross Profit$12.7B$15.7B$14.2B$12.7B$11.9B$11.2B$10.3B$10.1B$9.6B$9.3B$8.7B$8.1B$7.3B$6.5B$6.2B$6.0B$4.2B$2.3B$2.2B$4.0B$3.6B
Gross Margin %71.3%90.5%90.0%89.3%89.0%88.7%88.9%89.0%89.1%89.4%89.4%89.2%90.6%89.9%88.5%79.4%75.1%44.2%43.7%84.5%85.3%
Operating Income (EBIT)$2.0B$2.0B$1.7B$1.2B$1.0B$1.4B$1.4B$1.2B$1.2B$1.3B$1.3B$1.3B$1.1B$1.0B$943M$897M$506M$521M$410M$370M$322M
Operating Margin %11.5%11.5%10.6%8.2%7.5%10.8%11.8%10.7%10.9%12.3%13.1%13.9%13.2%13.9%13.5%12.0%9.1%10.0%8.2%7.8%7.7%
Net Income$1.5B$1.5B$1.1B$718M$676M$992M$944M$815M$780M$752M$702M$681M$545M$511M$443M$398M$230M$260M$199M$170M$259M
Net Margin %8.6%8.6%7.2%5.0%5.0%7.8%8.2%7.2%7.2%7.2%7.2%7.5%6.8%7.0%6.4%5.3%4.1%5.0%4.0%3.6%6.2%
EBITDA$2.8B$2.7B$2.3B$1.7B$1.6B$1.9B$1.9B$1.7B$1.6B$1.7B$1.7B$1.6B$1.4B$1.3B$1.2B$1.2B$720M$726M$607M$511M$450M
Earnings Per Share (EPS)$23.74$23.10$16.82$10.24$9.15$11.85$11.03$9.15$8.32$7.81$7.14$6.76$5.42$5.14$4.54$4.04$2.35$2.65$1.97$1.59$2.24
Shares Outstanding (M)62M64M68M70M74M84M86M89M94M96M98M101M101M99M98M99M98M98M101M107M116M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

UHS Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue$4.5B$4.5B$4.5B$4.3B$4.1B$4.1B$4.0B$3.9B
Gross Profit$658M$4.1B$4.1B$3.9B$3.7B$3.7B$3.6B$3.5B
Gross Margin %14.6%90.6%90.8%90.2%90.2%90.1%90.1%90.1%
Operating Income (EBIT)$503M$517M$522M$500M$455M$472M$384M$436M
Operating Margin %11.2%11.5%11.6%11.7%11.1%11.5%9.7%11.2%
Net Income$349M$446M$373M$353M$317M$332M$259M$289M
Net Margin %7.8%9.9%8.3%8.2%7.7%8.1%6.5%7.4%
EBITDA$662M$786M$689M$660M$608M$624M$535M$577M
Earnings Per Share (EPS)$5.65$6.92$5.74$5.43$4.80$4.96$3.80$4.26
Shares Outstanding (M)62M64M65M65M66M67M68M68M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

UHS Free Cash Flow History

Cash flowTTM → 2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Cash from Operations (CFO)$1.9B$1.9B$2.1B$1.3B$996M$884M$2.4B$1.4B$1.3B$1.2B$1.3B$1.0B$1.0B$884M$815M$718M$501M$533M$463M$348M$169M
Capital Expenditures (CapEx)$1.0B$1.0B$944M$743M$734M$856M$734M$664M$812M$609M$1.2B$913M$823M$371M$891M$324M$239M$380M$355M$340M$341M
Free Cash Flow (FCF)$894M$849M$1.1B$525M$262M$28M$1.6B$775M$529M$573M$133M$108M$213M$513M($76M)$394M$262M$154M$109M$9M($172M)
FCF Margin %5.0%4.9%7.1%3.7%2.0%0.2%14.1%6.8%4.9%5.5%1.4%1.2%2.6%7.0%-1.1%5.3%4.7%2.9%2.2%0.2%-4.1%
Dividends Paid$51M$51M$53M$55M$58M$66M$17M$53M$37M$38M$39M$40M$30M$20M$58M$19M$19M$17M$16M$17M$17M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

UHS Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Cash from Operations (CFO)$402M$575M$381M$549M$360M$658M$333M$679M
Capital Expenditures (CapEx)$217M$281M$248M$266M$239M$246M$248M$241M
Free Cash Flow (FCF)$184M$293M$133M$283M$121M$412M$85M$438M
FCF Margin %4.1%6.5%3.0%6.6%2.9%10.0%2.1%11.2%
Dividends Paid$13M$12M$12M$13M$14M$13M$13M$13M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

UHS Balance Sheet History

Balance sheet2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Assets$15.7B$16.0B$14.5B$14.0B$13.5B$13.1B$13.5B$11.7B$11.3B$10.8B$10.3B$9.6B$9.0B$8.3B$8.2B$7.7B$7.5B$4.0B$3.7B$3.6B$3.3B
Cash & Cash Equivalents$119M$138M$126M$119M$103M$115M$1.2B$61M$105M$74M$34M$61M$32M$17M$23M$41M$29M$9M$5M$16M$15M
Total Liabilities$8.1B$8.5B$7.7B$7.8B$7.5B$6.9B$7.1B$6.1B$5.8B$5.7B$5.7B$5.1B$4.9B$4.8B$5.2B$5.1B$5.3B$2.0B$2.0B$2.1B$1.7B
Total Debt (Short + Long-Term)$4.8B$4.8B$4.6B$5.0B$4.9B$4.3B$3.9B$4.0B$4.0B$4.0B$4.1B$3.5B$3.3B$3.3B$3.7B$3.7B$3.9B$959M$999M$1.0B$823M
Total Shareholders' Equity$7.5B$7.3B$6.7B$6.1B$5.9B$6.1B$6.3B$5.5B$5.4B$5.0B$4.5B$4.2B$3.7B$3.2B$2.7B$2.3B$2.0B$1.8B$1.5B$1.5B$1.4B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive UHS viewer.

Other Companies in Health Care Facilities

← UHAL.BAll stocksUHT →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.